ArticleACS medicinal chemistry letters2018

Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes.

Santhosh F Neelamkavil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.